1. Home
  2. DOX vs BIO Comparison

DOX vs BIO Comparison

Compare DOX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amdocs Limited

DOX

Amdocs Limited

HOLD

Current Price

$66.37

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$262.80

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOX
BIO
Founded
1982
1952
Country
United States
United States
Employees
N/A
7450
Industry
EDP Services
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.1B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
DOX
BIO
Price
$66.37
$262.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$92.33
$358.50
AVG Volume (30 Days)
1.4M
302.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.46
$2.51
Revenue Next Year
$3.72
$3.17
P/E Ratio
$13.65
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$65.74
$211.43
52 Week High
$94.61
$343.12

Technical Indicators

Market Signals
Indicator
DOX
BIO
Relative Strength Index (RSI) 33.69 36.10
Support Level N/A $239.33
Resistance Level $70.61 $264.68
Average True Range (ATR) 1.92 7.79
MACD 0.17 -0.22
Stochastic Oscillator 13.39 12.17

Price Performance

Historical Comparison
DOX
BIO

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: